Aflibercept in epithelial ovarian carcinoma

By Moroney John W   Sood Anil K   Coleman Robert L  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 591-600

Future Medicine

Access to resources Recommend Favorite

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

By Chi D.S.   Liao J.B.   Leon L.F.   Venkatraman E.S.   Hensley M.L.   Bhaskaran D.   Hoskins W.J.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 532-537

Elsevier

Access to resources Recommend Favorite

Secretion of Activin A in Recurrent Epithelial Ovarian Carcinoma

By Lambert-Messerlian G.M.   DePasquale S.E.   Maybruck W.M.   Steinhoff M.M.   Gajewski W.H.  

Gynecologic Oncology, Vol. 74, Iss. 1, 1999-07 ,pp. : 93-97

Elsevier

Access to resources Recommend Favorite

Evaluation of Chemoresistance Markers in Women with Epithelial Ovarian Carcinoma

By Goff B.A.   Paley P.J.   Greer B.E.   Gown A.M.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 18-24

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian Carcinoma

By Scarabelli C.   Gallo A.   Carbone A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 504-512

Elsevier

Access to resources Recommend Favorite